Breast Cancer
FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer
BY JASON M. BRODERICK
FDA Approves Tucatinib to Treat HER2+ Breast Cancer
BY JASON M. BRODERICK
COVID-19 Breast Cancer Recommendations Stratify Patients by Risk
BY BRIELLE BENYON
Oncology Nursing News: Top Stories of March 2020
BY JESSICA SKARZYNSKI
Making Cold Breast Cancer Tumors Hot
BY HOPE S. RUGO, MD, FASCO
Genetic Risk, Assessment, Application, and Recommendations in Breast Cancer
BY THERESA WICKLIN GILLESPIE, PHD, MA, RN, FAAN, EMORY UNIVERSITY
Expert Discusses Implant-Associated Lymphoma
BY BRIELLE BENYON
Nurses, Get to Know Your Patients. It Means More Than You Think
BY BARBARA BIGELOW
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.